Simple jQuery Dropdowns

Browsing by Author Oliver Bautista

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
1-Dec-2020Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-upSven Eric Olsson; Jaime Alberto Restrepo; Julio Cesar Reina; Punnee Pitisuttithum; Angels Ulied; Meera Varman; Pierre Van Damme; Edson Duarte Moreira; Daron Ferris; Stanley Block; Oliver Bautista; Nancy Gallagher; Jennifer McCauley; Alain Luxembourg; Centro Médico Imbanaco; Augusta University; Danderyd Hospital; Fundacao Oswaldo Cruz; Universiteit Antwerpen; Mahidol University; Creighton University; Merck & Co., Inc.; Foundation Clinical Research Center CIC; Pediatrics Department; Kentucky Pediatric and Adult Research Inc
1-Jun-2012Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccineKatie Matys; Sara Mallary; Oliver Bautista; Scott Vuocolo; Ricardo Manalastas; Punee Pitisuttithum; Alfred Saah; MRL; Merck & Co., Inc.; Philippine General Hospital; Mahidol University; PPD Vaccine and Biologics
5-Jun-2009Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trialNubia Muñoz; Ricardo Manalastas; Punee Pitisuttithum; Damrong Tresukosol; Joseph Monsonego; Kevin Ault; Christine Clavel; Joaquin Luna; Evan Myers; Sara Hood; Oliver Bautista; Janine Bryan; Frank J. Taddeo; Mark T. Esser; Scott Vuocolo; Richard M. Haupt; Eliav Barr; Alfred Saah; National Cancer Institute; Philippine General Hospital; Mahidol University; King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University; Federation Mutualiste Parisienne; Emory University School of Medicine; CHU de Reims; Duke University School of Medicine; Merck & Co., Inc.
1-Jan-2021Three-year follow-up of 2-dose versus 3-dose HPV vaccineJacob Bornstein; Surita Roux; Lone Kjeld Petersen; Li Min Huang; Simon R. Dobson; Punnee Pitisuttithum; Javier Diez-Domingo; Andrea Schilling; Hany Ariffin; Richard Tytus; Richard Rupp; Shelly Senders; Eli Engel; Daron Ferris; Yae Jean Kim; Young Tae Kim; Zafer Kurugol; Oliver Bautista; Katrina M. Nolan; Sandhya Sankaranarayanan; Alfred Saah; Alain Luxembourg; National Taiwan University Hospital; Medical College of Georgia; Ege Üniversitesi; Yonsei University College of Medicine; Odense Universitetshospital; UT Medical Branch at Galveston; University of Malaya Medical Centre; Mahidol University; The University of British Columbia; Merck & Co., Inc.; Sungkyunkwan University; Bar-Ilan University; Clinica Alemana; Bayview Research Group; Synexus Clinical Research SA; Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO); Senders Pediatrics; Hamilton Medical Research Group